Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28 days of abstinence

Psychopharmacology

Volumn 235, Issue 3, 2018, Pages 849-859

  Zimmermann, Kaeli ^a   Yao, Shuxia ^b   Heinz, Marcel ^a   Zhou, Feng ^b   Dau, Wolfgang ^c   Banger, Markus ^c   Weber, Bernd ^a,d   Hurlemann, René ^a   Becker, Benjamin ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c Abteilung fr Suchterkrankungen und Psychotherapie LVR Klinik Bonn   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Abstinence; Amygdala; Cannabis; Emotion; fMRI; Marijuana; Orbitofrontal cortex; Striatum; Substance dependence

Indexed keywords

ABSTINENCE; ADAPTATION; ADULT; AMYGDALA; AROUSAL; ARTICLE; BRAIN FUNCTION; CANNABIS ADDICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DORSAL STRIATUM; EMOTION; FEMALE; FUNCTIONAL CONNECTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; ORBITAL CORTEX; PRIORITY JOURNAL; RISK FACTOR; TASK PERFORMANCE; ADDICTION; ADOLESCENT; ANALYSIS OF VARIANCE; BRAIN CORTEX; BRAIN MAPPING; CASE CONTROL STUDY; FRONTAL LOBE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOLOGY; VISUAL CORTEX; YOUNG ADULT;

CANNABIS;

ADOLESCENT; ADULT; AMYGDALA; ANALYSIS OF VARIANCE; BEHAVIOR, ADDICTIVE; BRAIN MAPPING; CANNABIS; CASE-CONTROL STUDIES; CEREBRAL CORTEX; EMOTIONS; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; PREFRONTAL CORTEX; VISUAL CORTEX; YOUNG ADULT;

EID: 85035805601     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-017-4803-6     Document Type: Article

References (80)

1. Andersson JL, Jenkinson M, Smith S (2007) Non-linear registration, aka spatial normalisation FMRIB technical report TR07JA2 2007. FMRIB Analysis Group of the University of Oxford, 2
2. Bayrakçı A, Sert E, Zorlu N, Erol A, Sarıçiçek A, Mete L (2015) Facial emotion recognition deficits in abstinent cannabis dependent patients. Compr Psychiatry 58:160–164. doi:10.1016/j.comppsych.2014.11.008
3. Beck AT, Steer RA, Brown GK (1996) Beck depression inventory-II. Psychological Corporation, San Antonio, TX
4. Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J (2010) The impact of early-onset cannabis use on functional brain correlates of working memory. Prog Neuro-Psychopharmacol Biol Psychiatry 34(6):837–845. doi:10.1016/j.pnpbp.2010.03.032
5. Beucke JC, Sepulcre J, Talukdar T, Linnman C, Zschenderlein K, Endrass T, Kaufmann C, Kathmann N (2013) Abnormally high degree of connectivity of orbitofrontal cortex in obsessive-compulsive disorder. JAMA Psychiatry 70(6):619–629. doi:10.1001/jamapsychiatry.2013.173
6. Bhattacharyya S, Crippa JA, Allen P, Martín-Santos R, Borgwardt S, Fusar-Poli P et al (2012) Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry 69(1):27–36. doi:10.1001/archgenpsychiatry.2011.161
7. Bhattacharyya S, Falkenberg I, Martín-Santos R, Atakan Z, Crippa JA, Giampietro V et al (2015) Cannabinoid modulation of functional connectivity with regions processing attentional salience. Neuropsychopharmacology 40(6):1343–1352. doi:10.1038/npp.2014.258
8. Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, Kambeitz J, Malhi S et al (2017) Impairment of inhibitory control processing related to acute psychomimetic effects of cannabis. Eur Neuropsychopharmacol 25:26–37
9. Blanco-Hinojo L, Pujol J, Harrison BJ, Macia D, Batalla A, Nogue S et al (2016) Attenuated frontal and sensory inputs to the basal ganglia in cannabis users. Addict Biol e-pub ahead of print 3 March 2016; doi:https://doi.org/10.1111/adb.12370
10. Boden MT, Gross JJ, Babson KA, Bonn-Miller MO (2013) The interactive effects of emotional clarity and cognitive reappraisal on problematic cannabis use among medical cannabis users. Addict Behav 38(3):1663–1668. doi:10.1016/j.addbeh.2012.09.001
11. Bolla KI, Eldreth DA, Matochik JA, Cadet JL (2005) Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage 26(2):480–492. doi:10.1016/j.neuroimage.2005.02.012
12. Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM (2013) The endocannabinoid system and emotional processing: a pharmacological fMRI study with delta-9-tetrahydrocannabinol. Eur Neuropsychopharmacol 23(12):1687–1697. doi:10.1016/j.euroneuro.2013.06.009
13. Brickenkamp R, Zillmer E (1998) The d2 test of attention, 1st U.S. Edn. eds Hogrefe and Huber, WA, Seattle
14. Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N (2016) Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiatry 79(7):557–567. doi:10.1016/j.biopsych.2015.12.002
15. Budney AJ, Moore BA, Vandrey RG, Hughes JR (2003) The time course and significance of cannabis withdrawal. J Abnorm Psychol 112(3):393–402. doi:10.1037/0021-843X.112.3.393
16. Carretie L, Rios M, de la Gandara BS, Tapia M, Albert J, Lopez-Martin S et al (2009) The striatum beyond reward: caudate responds intensely to unpleasant pictures. Neuroscience 164(4):1615–1622. doi:10.1016/j.neuroscience.2009.09.031
17. Chang L, Yakupov R, Cloak C, Ernst T (2006) Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 129(5):1096–1112. doi:10.1093/brain/awl064
18. Charlet K, Schlagenhauf F, Richter A, Naundorf K, Dornhof L, Weinfurtner CE et al (2014) Neural activation during processing of aversive faces predicts treatment outcome in alcoholism. Addict Biol 19(3):439–451. doi:10.1111/adb.12045
19. Cheetham A, Allen NB, Yücel M, Lubman DI (2010) The role of affective dysregulation in drug addiction. Clin Psychol Rev 30(6):621–634. doi:10.1016/j.cpr.2010.04.005
20. Chye Y, Solowij N, Suo C, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S, Lorenzetti V, Yücel M (2017a) Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users. Psychopharmacology (Berli) e-pub ahead of print 1 April 2017; doi:https://doi.org/10.1007/s00213-017-4606-9
21. Chye Y, Solowij N, Ganella EP, Suo C, Yücel M, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S, Bartholomeusz CF, Lorenzetti V (2017b) Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms. Prog Neuro-Psychopharmacol Biol Psychiatry 79(Pt B):392–400. doi:10.1016/j.pnpbp.2017.07.017
22. Contreras-Rodriguez O, Albein-Urios N, Vilar-Lopez R, Perales JC, Martinez-Gonzalez JM, Fernandez-Serrano MJ et al (2016) Increased corticolimbic connectivity in cocaine dependence versus pathological gambling is associated with drug severity and emotion-related impulsivity. Addict Biol 21:709–718
23. Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Porrino LJ, Goudriaan AE (2013) Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addict Biol 18(6):1013–1023. doi:10.1111/j.1369-1600.2012.00498.x
24. Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE (2014) Effect of baseline cannabis use and working-memory network function on changes in cannabis use in heavy cannabis users: a prospective fMRI study. Hum Brain Mapp 35(5):2470–2482. doi:10.1002/hbm.22342
25. Crawford JR, Henry JD (2004) The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol 43(3):245–265. doi:10.1348/0144665031752934
26. Cunningham WA, Kesek A, Mowrer SM (2009) Distinct orbitofrontal regions encode stimulus and choise valuation. J Cogn Neurosci 21(10):1956–1966. doi:10.1162/jocn.2008.21148
27. Di Martino A, Scheres A, Marguelies DS, Kelly AM, Uddin LQ, Shehzad Z et al (2008) Functional connectivity of the human striatum: a resting state FMRI study. Cereb Cortex 18(12):2735–2747. doi:10.1093/cercor/bhn041
28. Elliott R, Agnew Z, Deakin JF (2010) Hedonic and informational functions of the human orbitofrontal cortex. Cereb Cortex 20(1):198–204. doi:10.1093/cercor/bhp092
29. European Monitoring Centre for Drugs and Drug Addiction (2016) European Drug Report: Trends and Developments. http://www.emcdda.europa.eu/system/files/publications/2637/TDAT16001ENN.pdf
30. Everitt BJ, Robbins TW (2013) From ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev 37(9):1946–1954. doi:10.1016/j.neubiorev.2013.02.010
31. Everitt BJ, Robbins TW (2016) Drug addiction: updating to actions to habits to compulsions ten years on. Annu Rev Psychol 67(1):23–50. doi:10.1146/annurev-psych-122414-033457
32. Filbey F, Yezhuvath U (2013) Functional connectivity in inhibitory control networks and severity of cannabis uses disorder. Am J Drug Alcohol Abuse 39(6):382–391. doi:10.3109/00952990.2013.841710
33. Ganzer F, Bröning S, Kraft S, Sack PM, Thomasius R (2016) Weighing the evidence: a systematic review on long-term neurocognitive effects of cannabis user in abstinent adolescents and adults. Neuropsychol Rev 26(2):186–222. doi:10.1007/s11065-016-9316-2
34. Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L (2016) Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev 5:CD005336. doi:10.1002/14651858.CD005336.pub4
35. George O, Koob GF (2010) Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev 35(2):232–247. doi:10.1016/j.neubiorev.2010.05.002
36. Gremel CM, Costa RM (2013) Orbitofrontal and striatal circuits dynamically encode the shift between goal-directed and habitual actions. Nat Commun 4:2264. doi:10.1038/ncomms3264
37. Gremel CM, Chancey JH, Atwood BK, Luo G, Neve R, Ramakrishnan C, Deisseroth K, Lovinger DM, Costa RM (2016) Endocannabinoid modulation of orbitofrontal circuits gates habit formation. Neuron 90(6):1312–1324. doi:10.1016/j.neuron.2016.04.043
38. Gruber SA, Rogowska J, Yurgelun-Todd DA (2009) Altered affective response in marijuana smokers: an fMRI study. Drug Alcohol Depend 105(1-2):139–153. doi:10.1016/j.drugalcdep.2009.06.019
39. Hayes DJ, Duncan NW, Xu J, Northoff G (2014) A comparison of neural responses to appetitive and aversive stimuli in humans and other mammals. Neurosci Biobehav Rev 45:350–368. doi:10.1016/j.neubiorev.2014.06.018
40. Heitzeg MM, Cope LM, Martz ME, Hardee JE, Zucker RA (2015) Brain activation to negative stimuli mediates a relationship between adolescent marijuana use and later emotional functioning. Dev Cogn Neurosci 16:71–83. doi:10.1016/j.dcn.2015.09.003
41. Jacobus J, Squeglia LM, Escobar S, McKenna BM, Hernandez MM, Bagot KS et al (2017) Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users. Psychopharmacology (Berl.) e-pub ahead of print 12 September 2017; doi:https://doi.org/10.1007/s00213-017-4725-3
42. Jarbo K, Verstynen TD (2015) Converging structural and functional connectivity of orbitofrontal, dorsolateral prefrontal, and posterior parietal cortex in the human striatum. J Neurosci 35(9):3865–3878. doi:10.1523/JNEUROSCI.2636-14.2015
43. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17(2):825–841. doi:10.1006/nimg.2002.1132
44. Lawrence NS, Jollant F, O’Daly O, Zelaya F, Phillips ML (2009) Distinct roles of prefrontal cortical subregions in the Iowa Gambling Task. Cereb Cortex 19(5):1134–1143. doi:10.1093/cercor/bhn154
45. Lee D, Schroeder JR, Karschner EL, Goodwin RS, Hirvonen J, Gorelick DA, Huestis MA (2014) Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. Am J Addict 23(3):234–242. doi:10.1111/j.1521-0391.2014.12088.x
46. Liu X, Hairston J, Schrier M, Fan J (2011) Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev 35(5):1219–1236. doi:10.1016/j.neubiorev.2010.12.012
47. Luijten M, Schellekens AF, Kühn S, Machielse MW, Sescousse G (2017) Disruption of reward processing in addiction: an image-based analysis of functional magnetic resonance imaging studies. JAMA Psychiatry e-pub ahead of print 1 April 2017; doi:https://doi.org/10.1001/jamapsychiatry.2016.3084
48. Mackie K (2008) Cannabinoid receptors: where they are and what they do. J Neuroendocrinol 20(Suppl 1):10–14. doi:10.1111/j.1365-2826.2008.01671.x
49. Martin GW, Wilkinson DA, Kapur BM (1988) Validation of self-reported cannabis use by urine analysis. Addict Behav 13(2):147–150. doi:10.1016/0306-4603(88)90004-4
50. Martín-Santos R, Fagundo AB, Crippa JA, Atakan Z, Bhattacharyya S, Allen P, Fusar-Poli P, Borgwardt S, Seal M, Busatto GF, McGuire P (2010) Neuroimaging in cannabis use: a systematic review of the literature. Psychol Med 40(03):383–398. doi:10.1017/S0033291709990729
51. McGilveray IJ (2005) Pharmacokinetics of cannabinoids. Pain Res Manag 10:15–22
52. McLaren DG, Ries ML, Xu G, Johnson SC (2012) A generalized form of context-dependent psychophysiological interactions (gPPI): a comparison to standard approaches. NeuroImage 61(4):1277–1286. doi:10.1016/j.neuroimage.2012.03.068
53. Metzler P, Schmidt KH (1992) Wortschatztest (WST). Beltz Test GmbH, Weinheim
54. Nestor L, Hester R, Garavan H (2010) Increased ventral striatal BOLD activity during non-reward anticipation in cannabis users. NeuroImage 49(1):1133–1143. doi:10.1016/j.neuroimage.2009.07.022
55. Ochsner KN, Gross JJ (2005) The cognitive control of emotion. Trends Cogn Sci 9(5):242–249. doi:10.1016/j.tics.2005.03.010
56. Phillips ML, Williams LM, Heining M, Herba CM, Russell T, Andrew C, Bullmore ET, Brammer MJ, Williams SCR, Morgan M, Young AW, Gray JA (2004) Differential neural responses to overt and covert presentations of facial expressions of fear and disgust. NeuroImage 21(4):1484–1496. doi:10.1016/j.neuroimage.2003.12.013
57. Phillips ML, Ladouceur CD, Drevets WC (2008) A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 829:833–857
58. Pruim RH, Mennes M, van Rooij D, Llera A, Buitelaar JK, Beckmann CF (2015) ICA-AROMA: a robust ICA-based strategy for removing motion artifacts from fMRI data. NeuroImage 112:267–277. doi:10.1016/j.neuroimage.2015.02.064
59. Rabinak CA, Sripada CS, Angstadt M, de Wit H, Phan KL (2012) Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. J Neural Transm (Vienna) 119(6):701–707. doi:10.1007/s00702-011-0747-x
60. Sabatinelli D, Fortune EE, Li Q, Siddiqui A, Krafft C, Oliver WT, Beck S, Jeffries J (2011) Emotional perception: meta-analyses of faces and natural scene processing. NeuroImage 54(3):2524–2533. doi:10.1016/j.neuroimage.2010.10.011
61. Schreiner AM, Dunn ME (2012) Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis. Exp Clin Psychopharmacol 20(5):420–429. doi:10.1037/a0029117
62. Schweinsburg AD, Nagel BJ, Schweinsburg BC, Park A, Theilmann RJ, Tapert SF (2008) Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res 163(1):40–51. doi:10.1016/j.pscychresns.2007.04.018
63. Shenhav A, Barrett LF, Bar M (2013) Affective value and associative processing share a cortical substrate. Cogn Affect Behav Neurosci 13(1):46–59. doi:10.3758/s13415-012-0128-4
64. Simons J, Correia CJ, Carey KB (2000) A comparison of motives for marijuana and alcohol use among experienced users. Addict Behav 25(1):153–160. doi:10.1016/S0306-4603(98)00104-X
65. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17(3):143–155. doi:10.1002/hbm.10062
66. Smith DG, Simon Jones P, Bullmore ET, Robbins TW, Ersche KD (2014) Enhanced orbitofrontal cortex function and lack of attentional bias to cocaine cues in recreational stimulant users. Biol Psychiatry 75(2):124–131. doi:10.1016/j.biopsych.2013.05.019
67. Sneider JT, Pope HG Jr, Silveri MM, Simpson NS, Gruber SA, Yurgelun-Todd DA (2008) Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers. Eur Neuropsychopharmacol 18(8):612–619. doi:10.1016/j.euroneuro.2008.04.016
68. Somaini L, Manfredini M, Amore M, Zaimovic A, Raggi MA, Leonardi C, Gerra ML, Donnini C, Gerra G (2012) Psychobiological responses to unpleasant emotions in cannabis users. Eur Arch Psychiatry Clin Neurosci 262(1):47–57. doi:10.1007/s00406-011-0223-5
69. Stevens L, Verdejo-García A, Goudriaan AE, Roeyers H, Dom G, Vanderplasschen W (2014) Impulsivity as a vulnerability factor for poor addiction treatment outcomes: a review of neurocognitive findings among individuals with substance use disorders. J Subst Abus Treat 47(1):58–72. doi:10.1016/j.jsat.2014.01.008
70. Tanaka SC, Doya K, Okada G, Ueda K, Okamoto Y, Yamawaki S (2004) Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nat Neurosci 7(8):887–893. doi:10.1038/nn1279
71. Tapert SF, Schweinsburg AD, Drummond SP, Paulus MP, Brown SA, Yang TT et al (2007) Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology 194(2):173–183. doi:10.1007/s00213-007-0823-y
72. United Nations Office on Drugs and Crime (2016) World Drug Report. http://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf
73. Van den Brink W (2012) Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev 5(1):3–31. doi:10.2174/1874473711205010003
74. Verdejo-García A, Bechara A, Recknor EC, Pérez-García M (2006) Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc 12(3):405–415
75. Volkow ND (2004) The reality of comorbity: depression and drug abuse. Biol Psychiatry 56(10):714–717. doi:10.1016/j.biopsych.2004.07.007
76. Weierich MR, Wright CI, Negreira A, Dickerson BC, Barrett LF (2010) Novelty as a dimension in the affective brain. NeuroImage 49(3):2871–2878. doi:10.1016/j.neuroimage.2009.09.047
77. Wesley MJ, Lile JA, Hanlon CA, Porrino LJ (2016) Abnormal prefrontal cortex activity in heavy cannabis users during conscious emotional evaluation. Psychopharmacology 233(6):1035–1044. doi:10.1007/s00213-015-4180-y
78. Wetherill RR, Childress AR, Jagannathan K, Bender J, Young KA, Suh JJ, O’Brien CP, Franklin TR (2014) Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals. Psychopharmacology 231(7):1397–1407. doi:10.1007/s00213-013-3342-z
79. Wittchen HU, Zaudig M, Fydrich T (1997) Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Hogrefe, Göttingen
80. Zimmermann K, Walz C, Derckx RT, Kendrick KM, Weber B, Dore B, Ochsner KN, Hurlemann R, Becker B (2017) Emotion regulation deficits in regular marijuana users. Hum Brain Mapp 38(8):4270–4279. doi:10.1002/hbm.23671